Levita Magnetics’ magnetic surgical platform, MARS, has officially debuted in Florida at HCA Florida Mercy Hospital in Miami. Developed by Alberto Rodríguez-Navarro, the FDA-cleared technology utilizes Dynamic Magnetic Positioning to guide instruments externally, reducing traditional incisions and associated scarring during minimally invasive procedures.
The expansion of Levita Magnetics into Florida marks a milestone for the Silicon Valley-based medical technology company, which has already established a presence in several healthcare systems across the United States. Following authorizations from the U.S. Food and Drug Administration (FDA), the MARS platform has been deployed in more than 2,500 surgeries.
Understanding the Mechanism of Action in Magnetic Surgery
The MARS platform operates on a core principle known as Dynamic Magnetic Positioning, utilizing external magnetic forces to manipulate and retract internal tissue. Traditional laparoscopic procedures typically require multiple small abdominal incisions to accommodate both surgical instruments and specialized retraction tools or cameras. In contrast, the magnetic system anchors to instruments inside the abdominal cavity, allowing the operating surgeon to control tissue retraction and visualization externally via an extracorporeal magnet.
By eliminating the need for extra port sites, this technique alters the biomechanical footprint of the procedure. Furthermore, the platform allows the primary surgeon to directly control both the camera and the magnetic retractor, bypassing the requirement for an additional assistant at the table. This direct control minimizes intraoperative distractions and optimizes workflow within the sterile surgical environment.
Clinical data supporting the platform includes multiple prospective trials. The pivotal clinical trial evaluating the foundational Levita Magnetic Surgical System reported patient satisfaction rates ranging between 94% and 96%, alongside an average return-to-work timeline of five days. Subsequent prospective evaluation specifically targeting the MARS platform demonstrated that 92.5% of patients reported being very satisfied with the system and 97.5% affirmed they would recommend it to others.
Clinical Integration and Bariatric Surgery Trends
The introduction of the MARS platform at HCA Florida Mercy Hospital was led by Dr. Nestor de la Cruz-Muñoz, a bariatric surgeon who performed the initial procedures in the state. Commenting on the transition, Dr. de la Cruz-Muñoz noted that the platform integrated seamlessly into existing surgical workflows, providing stable visualization and consistent retraction throughout complex interventions.
This deployment coincides with a broader shift in metabolic and bariatric surgery. Consequently, healthcare providers are observing a renewed interest in durable surgical alternatives.
By pairing traditional bariatric techniques with port-reduction technologies like MARS, surgical teams aim to mitigate the physical toll of interventions. According to Alberto Rodríguez-Navarro, co-founder of Levita Magnetics, the primary objective of the expansion remains centered on patient recovery. Reducing surgical trauma helps patients resume normal physiological activities more rapidly, paving the way for broader adoption across national institutions.
In Plain English: The Clinical Takeaway
- Fewer Incisions: Magnetic surgical tools use external magnets to hold and move internal tissues, cutting down on the number of small cuts required on the abdomen.
- Surgeon-Led Control: The primary surgeon directly controls both the camera and the magnetic retractor, removing the need for a secondary camera operator and improving operating room coordination.
- Rapid Recovery: Clinical studies show high satisfaction rates and faster recovery metrics, with patients averaging a return to normal daily routines within five days.
Contraindications & When to Consult a Doctor
| Metric | Reported Data / Outcome |
|---|---|
| Regulatory Status | FDA Cleared |
| Total Procedures Performed | Over 2,500 surgeries |
| Patient Satisfaction (MARS Trial) | 92.5% very satisfied; 97.5% would recommend |
| Average Return to Work | Approximately 5 days |
| Prominent U.S. Sites | Cleveland Clinic, Texas Health Plano, UT Southwestern, Stanford, HCA Florida Mercy Hospital |
